201 related articles for article (PubMed ID: 31541281)
21. Early-onset stroke and vasculopathy associated with mutations in ADA2.
Zhou Q; Yang D; Ombrello AK; Zavialov AV; Toro C; Zavialov AV; Stone DL; Chae JJ; Rosenzweig SD; Bishop K; Barron KS; Kuehn HS; Hoffmann P; Negro A; Tsai WL; Cowen EW; Pei W; Milner JD; Silvin C; Heller T; Chin DT; Patronas NJ; Barber JS; Lee CC; Wood GM; Ling A; Kelly SJ; Kleiner DE; Mullikin JC; Ganson NJ; Kong HH; Hambleton S; Candotti F; Quezado MM; Calvo KR; Alao H; Barham BK; Jones A; Meschia JF; Worrall BB; Kasner SE; Rich SS; Goldbach-Mansky R; Abinun M; Chalom E; Gotte AC; Punaro M; Pascual V; Verbsky JW; Torgerson TR; Singer NG; Gershon TR; Ozen S; Karadag O; Fleisher TA; Remmers EF; Burgess SM; Moir SL; Gadina M; Sood R; Hershfield MS; Boehm M; Kastner DL; Aksentijevich I
N Engl J Med; 2014 Mar; 370(10):911-20. PubMed ID: 24552284
[TBL] [Abstract][Full Text] [Related]
22. Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation.
Nihira H; Izawa K; Ito M; Umebayashi H; Okano T; Kajikawa S; Nanishi E; Keino D; Murakami K; Isa-Nishitani M; Shiba T; Honda Y; Hijikata A; Yasu T; Kubota T; Hasegawa Y; Kawashima Y; Nakano N; Takada H; Ohga S; Heike T; Takita J; Ohara O; Takei S; Takahashi M; Kanegane H; Morio T; Iwaki-Egawa S; Sasahara Y; Nishikomori R; Yasumi T
J Allergy Clin Immunol; 2021 Aug; 148(2):550-562. PubMed ID: 33529688
[TBL] [Abstract][Full Text] [Related]
23. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
[TBL] [Abstract][Full Text] [Related]
24. Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
Santo GC; Baldeiras I; Guerreiro R; Ribeiro JA; Cunha R; Youngstein T; Nanthapisal S; Leitão J; Fernandes C; Caramelo F; Almeida MDR; Brás J; Santana I;
Cerebrovasc Dis; 2018; 46(5-6):257-264. PubMed ID: 30645994
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.
Van Montfrans JM; Hartman EA; Braun KP; Hennekam EA; Hak EA; Nederkoorn PJ; Westendorp WF; Bredius RG; Kollen WJ; Schölvinck EH; Legger GE; Meyts I; Liston A; Lichtenbelt KD; Giltay JC; Van Haaften G; De Vries Simons GM; Leavis H; Sanders CJ; Bierings MB; Nierkens S; Van Gijn ME
Rheumatology (Oxford); 2016 May; 55(5):902-10. PubMed ID: 26867732
[TBL] [Abstract][Full Text] [Related]
26. Case Report: Interindividual variability and possible role of heterozygous variants in a family with deficiency of adenosine deaminase 2: are all heterozygous born equals?
Pulvirenti F; Cinicola BL; Ferrari S; Guadagnolo D; Sculco E; Capponi M; Loffredo L; Sciannamea M; Insalaco A; Quinti I; De Benedetti F; Zicari AM
Front Immunol; 2023; 14():1156689. PubMed ID: 37207212
[TBL] [Abstract][Full Text] [Related]
27. A Novel LC-MS/MS-Based Method for the Diagnosis of ADA2 Deficiency from Dried Plasma Spot.
Cafaro A; Pigliasco F; Barco S; Penco F; Schena F; Caorsi R; Volpi S; Tripodi G; Gattorno M; Cangemi G
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577178
[TBL] [Abstract][Full Text] [Related]
28. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
Navon Elkan P; Pierce SB; Segel R; Walsh T; Barash J; Padeh S; Zlotogorski A; Berkun Y; Press JJ; Mukamel M; Voth I; Hashkes PJ; Harel L; Hoffer V; Ling E; Yalcinkaya F; Kasapcopur O; Lee MK; Klevit RE; Renbaum P; Weinberg-Shukron A; Sener EF; Schormair B; Zeligson S; Marek-Yagel D; Strom TM; Shohat M; Singer A; Rubinow A; Pras E; Winkelmann J; Tekin M; Anikster Y; King MC; Levy-Lahad E
N Engl J Med; 2014 Mar; 370(10):921-31. PubMed ID: 24552285
[TBL] [Abstract][Full Text] [Related]
29. Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab.
Kisla Ekinci RM; Balci S; Bisgin A; Hershfield M; Atmis B; Dogruel D; Yilmaz M
Pediatrics; 2018 Nov; 142(5):. PubMed ID: 30377239
[TBL] [Abstract][Full Text] [Related]
30. Clinical presentation of children with Deficiency of Adenosine deaminase 2: A case series.
Kisla Ekinci RM; Anlas O; Ozalp O
Eur J Med Genet; 2022 Aug; 65(8):104555. PubMed ID: 35777620
[TBL] [Abstract][Full Text] [Related]
31. [Adenosine deaminase 2 deficiency: a disease with multiple presentations].
Caratsch L; Schnider C; Moi L; Theodoropoulou K; Candotti F; Hofer M
Rev Med Suisse; 2022 Apr; 18(776):669-673. PubMed ID: 35385618
[TBL] [Abstract][Full Text] [Related]
32. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
[TBL] [Abstract][Full Text] [Related]
33. Deficiency of adenosine deaminase 2: a challenging differential diagnosis of polyarteritis nodosa.
Hassanzadeh S; Bahadoram M; Mowla K
Reumatologia; 2023; 61(1):45-54. PubMed ID: 36998575
[TBL] [Abstract][Full Text] [Related]
34. A Novel Germline Mutation of
Vai S; Marin E; Cosso R; Saettini F; Bonanomi S; Cattoni A; Chiodini I; Persani L; Falchetti A
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361096
[TBL] [Abstract][Full Text] [Related]
35. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A
Front Immunol; 2022; 13():910021. PubMed ID: 36248833
[TBL] [Abstract][Full Text] [Related]
36. Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA2 Deficiency.
Insalaco A; Moneta GM; Pardeo M; Caiello I; Messia V; Bracaglia C; Passarelli C; De Benedetti F
J Rheumatol; 2019 May; 46(5):523-526. PubMed ID: 30647181
[TBL] [Abstract][Full Text] [Related]
37. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
Hashem H; Egler R; Dalal J
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e293-e296. PubMed ID: 28230570
[TBL] [Abstract][Full Text] [Related]
38. ADA2 deficiency (DADA2) associated with Evans syndrome and a severe ADA2 genotype.
Ferriani MPL; Valera ET; de Sousa GR; Sandrin-Garcia P; de Moura RR; Hershfield MS; de Carvalho LM
Rheumatology (Oxford); 2021 Jul; 60(7):e237-e239. PubMed ID: 33493352
[No Abstract] [Full Text] [Related]
39. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
40. Polyarteritis nodosa: an evolving primary systemic vasculitis.
Springer JM; Byram K
Postgrad Med; 2023 Jan; 135(sup1):61-68. PubMed ID: 35709399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
